Side Effects of Nifedipine
Nifedipine's most common side effects include peripheral edema (dose-related, occurring in 18-29% of patients), hypotension, dizziness, flushing, headache, nausea, and constipation 1, 2. The immediate-release formulation carries increased risks and should be avoided without concomitant beta-blocker therapy due to potential for serious cardiovascular complications 1.
Common Side Effects (Dose-Related)
Peripheral edema is the most frequently reported adverse effect, occurring in:
- 18% at 30 mg daily
- 22% at 60 mg daily
- 29% at 90 mg daily
- Compared to 10% with placebo 2
Other common effects include:
- Cardiovascular: Hypotension, dizziness, flushing, tachycardia, palpitations 1, 2, 3
- Neurological: Headache (very common), light-headedness 2
- Gastrointestinal: Nausea, constipation 1, 2
Serious Cardiovascular Risks
Major cardiovascular side effects warrant particular caution 1:
- Hypotension (can be severe)
- Worsening heart failure
- Reflex tachycardia
- Myocardial ischemia or infarction (especially with rapid-release formulations) 4
The rapid-release, short-acting formulation has documented cases of cardiac ischemia and infarction when used for hypertensive urgency 4. Immediate-release nifedipine must be avoided in the absence of concomitant beta blockade due to increased adverse potential 1.
Less Common but Important Side Effects
Dermatologic reactions (reported in <3% of patients) 2:
- Rash
- Rare cases of erythromelalgia-like syndrome (burning pain, erythema, increased skin temperature of extremities) 5, 6
- Fixed drug eruption 6
- Vasculitis 6
- Leg cramps
- Impotence/erectile dysfunction
- Gingival hyperplasia (rare)
- Sleep disturbances and confusion 3
Special Considerations for Obesity
Nifedipine is considered weight-neutral and is an appropriate antihypertensive choice for patients with obesity 7. Unlike beta-blockers or alpha-blockers, calcium channel blockers do not promote weight gain 7.
In obese hypertensive patients, nifedipine does not adversely affect:
Context for Livedo Reticularis
While the evidence does not specifically address nifedipine's interaction with livedo reticularis, the documented erythromelalgia-like syndrome (burning, erythema, vasodilation of extremities) 5 suggests potential for vascular cutaneous reactions. One case report describes acute erythema and burning sensation in feet and lower limbs occurring approximately 1 hour after nifedipine administration, which resolved within 24 hours of discontinuation 5.
Critical Monitoring Parameters
Monitor for:
- Blood pressure (risk of hypotension)
- Heart rate (reflex tachycardia)
- Peripheral edema development
- Signs of heart failure exacerbation
- Cutaneous reactions, particularly in extremities
The extended-release formulation is strongly preferred over immediate-release to minimize cardiovascular risks and side effect burden 1, 2.